Interaction between nitric oxide and prostanoids in arterioles of rat cremaster muscle in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Laemmel, E ^a   Bonnardel Phu, E ^a   Hou, X ^a   Seror, J ^a   Vicaut, E ^a  

^a HÔPITAL FERNAND WIDAL   (France)

Author keywords

Microcirculation; Oxidative stress; Prostaglandins; Vascular reactivity

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CATALASE; MEFENAMIC ACID; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; ENZYME INHIBITION; IN VIVO STUDY; MALE; MICROSCOPY; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0042860039     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00839.2002     Document Type: Article

References (38)

1. Baudry N and Vicaut E. Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in rat. J Appl Physiol 75: 2392-2399, 1993.
2. Bonnardel-Phu E and Vicaut E. Reactive oxygen species and acute modulation of albumin microvascular leakage in microcirculation of diabetic rats in vivo. J Vasc Res 37: 32-38, 2000.
3. Da Cunha V, Rossoni LV, Oliveira PA, Poton S, Pretti SC, Vassalo DV, and Stefanon I. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats. Clin Exp Hypertens 22: 203-215, 2000.
4. Danialou G, Vicaut E, Aubier M, and Boczkowski J. Theophylline dilates rat diaphragm arterioles via the prostaglandins pathway. Br J Pharmacol 124: 1355-1362, 1997.
5. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 16: 65-73, 1998.
6. Davidge ST, Baker PN, McLaughlin MK, and Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283, 1995.
7. De Wit C, Von Bismarck P, and Pohl U. Synergistic action of vasodilators that increase cGMP and cAMP in the hamster cremaster microcirculation. Cardiovasc Res 28: 1513-1518, 1994.
8. Delpy E, Coste H, and Gouville AC. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br J Pharmacol 119: 471-478, 1996.
9. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
10. Gryglewski RJ, Palmer RMJ, and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456, 1986.
11. Hajjar DP, Lander HM, Pearce SFA, Upmacis RK, and Pomerantz KB. Nitric oxide enhances prostaglandin-H synthase-1 activity by a heme-independent mechanism: evidence implicating nitrosothiols. J Am Chem Soc 117: 3340-3346, 1995.
12. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, and Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol Gastrointest Liver Physiol 266: G1004-G1010, 1994.
13. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, and Chemtob S. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 83: 721-729, 1998.
14. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627-630, 1992.
15. 2 in aorta of the spontaneously hypertensive rat. J Cardiovasc Pharmacol 33: 605-610, 1999.
16. 2 enhance arteriolar myogenic tone in hypertension. Hypertension 30: 1210-1215, 1997
17. 2) from endothelial cells. Wien Klin Wochenschr 103: 422-434, 1991.
18. Kanner J, Harel S, and Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27: 46-49, 1992.
19. Kossenjans W, Eis A, Sahay R, Brockman D, and Myatt L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 278: H1311-H1319, 2000.
20. Langenstroer P and Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol Heart Circ Physiol 263: H257-H265, 1992.
21. Mombouli JV and Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 35: 679-705, 1995.
22. G-nitroarginine (L-NNA), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99: 408-412, 1990.
23. Omar HA, Figueroa R, Omar RA, Tejani N, and Wolin MS. Hydrogen peroxide and reoxygenation cause prostaglandin-mediated contraction of human placental arteries and veins. Am J Obstet Gynecol 167: 201-207, 1992.
24. Palmer RMJ, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
25. Pou S, Pou W, Bredt DS, Snyder S, and Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176, 1992.
26. Rodríguez-Martínez MA, García-Cohen EC, Baena AB, Gonzalez R, Salaíces M, and Marín J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329-1335, 1998.
27. Rosenblum WI, Nishimura H, and Nelson GH. L-NMMA in brain microcirculation of mice is inhibited by blockade of cyclooxygenase and by superoxyde dismutase. Am J Physiol Heart Circ Physiol 262: H1343-H1349, 1992.
28. Salvemini D, Currie MG, and Mollace V. Nitric oxide-mediated cyclooxygenase activation. J Clin Invest 97: 2562-2568, 1996.
29. Sautebin L and Di Rosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur J Pharmacol 262: 193-196, 1994.
30. Soma M, Izumi Y, Watanabe Y, and Kanmatsuse K. A nitric oxide synthesis inhibitor decreased prostaglandin production in rat mesenteric vasculature. Prostaglandins 51: 225-232, 1996.
31. Taddei S, Virdis A, Ghiadoni L, Magagna A, and Salvetti A. Vitamin C improves endothelium-dependent vasodilatation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
32. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16: 383-391, 1994.
33. Vicaut E and Stücker O. An intact cremaster muscle preparation for studying the microcirculation by in vivo microscopy. Microvasc Res 39: 120-122, 1990.
34. 2 synthase. Arch Biochem Biophys 347: 174-180, 1997.
35. Wang GR, Zhu Y, Halushka PV, Lincoln TM, and Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95: 4888-4893, 1998.
36. Wang W and Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 233: 748-751, 1997.
37. Wolin MS, Davidson CA, Kaminski PM, Fayngersh RP, and Mohazzab-H KM. Oxidant-nitric oxide signalling mechanisms in vascular tissue. Biochemistry (Mosc) 63: 810-816, 1999.
38. Zweifach BW and Lipowsky HH. Pressure-flow relations in blood and lymph microcirculation. In: Handbook of Physiology. The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc., 1984, sect. 2, vol. IV, pt.1, chapt. 7, p. 251-308.